Industry Research Reports

Home > Reports > Pharma & Healthcare > Enasidenib - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Enasidenib - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published Date: 2024-01-24

Pages: 89 Pages

Report ld: 2342125

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Enasidenib Market Size(US$)

CAGR 2024-2030

7.1%

Market Size,2030

USD 125.9

Million

Market Snapshot

Market Size in 2024 (Value)

US$ 83 million

Market Forecast in 2030(Value)

US$ 125.9 million

CAGR

7.1%

Years Considered

2019-2030

Base Year

2024

Forecast Period

2024-2030

Source: Secondary research, interviews with experts, and QYResearch analysis

Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) gene, determined by an FDA-approved IDH2 companion diagnostic test

The global market for Enasidenib was estimated to be worth US$ 78 million in 2023 and is forecast to a readjusted size of US$ 125.9 million by 2030 with a CAGR of 7.1% during the forecast period 2024-2030

Enasidenib is a targeted therapy used to treat relapsed or refractory acute myeloid leukemia (AML) with an IDH2 mutation. Its efficacy in inhibiting the mutated IDH2 enzyme and inducing remission has driven market growth. The limited treatment options for this specific subset of AML contribute to its niche status. However, challenges include potential side effects and the need for genetic testing to identify eligible patients. The market competition is relatively small, as Enasidenib remains a targeted therapy for a specific AML subgroup. Despite challenges, the Enasidenib market offers potential for growth as healthcare providers seek effective treatments for patients with IDH2-mutated AML. Continued research and clinical advancements can further drive market expansion.

MARKET SEGMENTATION

By Company

Bristol Myers Squibb

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

50mg
100mg

Segment by Application

Hospital
Pharmacy

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Enasidenib, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Enasidenib by region & country, by Type, and by Application.

The Enasidenib market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enasidenib.

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Enasidenib manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Enasidenib in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Enasidenib in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Enasidenib Product Introduction

1.2 Global Enasidenib Market Size Forecast

1.2.1 Global Enasidenib Sales Value (2019-2030)

1.2.2 Global Enasidenib Sales Volume (2019-2030)

1.2.3 Global Enasidenib Sales Price (2019-2030)

1.3 Enasidenib Market Trends & Drivers

1.3.1 Enasidenib Industry Trends

1.3.2 Enasidenib Market Drivers & Opportunity

1.3.3 Enasidenib Market Challenges

1.3.4 Enasidenib Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Enasidenib Players Revenue Ranking (2023)

2.2 Global Enasidenib Revenue by Company (2019-2024)

2.3 Global Enasidenib Players Sales Volume Ranking (2023)

2.4 Global Enasidenib Sales Volume by Company Players (2019-2024)

2.5 Global Enasidenib Average Price by Company (2019-2024)

2.6 Key Manufacturers Enasidenib Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Enasidenib Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Enasidenib

2.9 Enasidenib Market Competitive Analysis

2.9.1 Enasidenib Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Enasidenib Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enasidenib as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 50mg

3.1.2 100mg

3.2 Global Enasidenib Sales Value by Type

3.2.1 Global Enasidenib Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Enasidenib Sales Value, by Type (2019-2030)

3.2.3 Global Enasidenib Sales Value, by Type (%) (2019-2030)

3.3 Global Enasidenib Sales Volume by Type

3.3.1 Global Enasidenib Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Enasidenib Sales Volume, by Type (2019-2030)

3.3.3 Global Enasidenib Sales Volume, by Type (%) (2019-2030)

3.4 Global Enasidenib Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital

4.1.2 Pharmacy

4.2 Global Enasidenib Sales Value by Application

4.2.1 Global Enasidenib Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Enasidenib Sales Value, by Application (2019-2030)

4.2.3 Global Enasidenib Sales Value, by Application (%) (2019-2030)

4.3 Global Enasidenib Sales Volume by Application

4.3.1 Global Enasidenib Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Enasidenib Sales Volume, by Application (2019-2030)

4.3.3 Global Enasidenib Sales Volume, by Application (%) (2019-2030)

4.4 Global Enasidenib Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Enasidenib Sales Value by Region

5.1.1 Global Enasidenib Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Enasidenib Sales Value by Region (2019-2024)

5.1.3 Global Enasidenib Sales Value by Region (2025-2030)

5.1.4 Global Enasidenib Sales Value by Region (%), (2019-2030)

5.2 Global Enasidenib Sales Volume by Region

5.2.1 Global Enasidenib Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Enasidenib Sales Volume by Region (2019-2024)

5.2.3 Global Enasidenib Sales Volume by Region (2025-2030)

5.2.4 Global Enasidenib Sales Volume by Region (%), (2019-2030)

5.3 Global Enasidenib Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Enasidenib Sales Value, 2019-2030

5.4.2 North America Enasidenib Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Enasidenib Sales Value, 2019-2030

5.5.2 Europe Enasidenib Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Enasidenib Sales Value, 2019-2030

5.6.2 Asia Pacific Enasidenib Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Enasidenib Sales Value, 2019-2030

5.7.2 South America Enasidenib Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Enasidenib Sales Value, 2019-2030

5.8.2 Middle East & Africa Enasidenib Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Enasidenib Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Enasidenib Sales Value

6.2.1 Key Countries/Regions Enasidenib Sales Value, 2019-2030

6.2.2 Key Countries/Regions Enasidenib Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Enasidenib Sales Value, 2019-2030

6.3.2 United States Enasidenib Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Enasidenib Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Enasidenib Sales Value, 2019-2030

6.4.2 Europe Enasidenib Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Enasidenib Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Enasidenib Sales Value, 2019-2030

6.5.2 China Enasidenib Sales Value by Type (%), 2023 VS 2030

6.5.3 China Enasidenib Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Enasidenib Sales Value, 2019-2030

6.6.2 Japan Enasidenib Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Enasidenib Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Enasidenib Sales Value, 2019-2030

6.7.2 South Korea Enasidenib Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Enasidenib Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Enasidenib Sales Value, 2019-2030

6.8.2 Southeast Asia Enasidenib Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Enasidenib Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Enasidenib Sales Value, 2019-2030

6.9.2 India Enasidenib Sales Value by Type (%), 2023 VS 2030

6.9.3 India Enasidenib Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Bristol Myers Squibb

7.1.1 Bristol Myers Squibb Company Information

7.1.2 Bristol Myers Squibb Introduction and Business Overview

7.1.3 Bristol Myers Squibb Enasidenib Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Bristol Myers Squibb Enasidenib Product Offerings

7.1.5 Bristol Myers Squibb Recent Development

8 Industry Chain Analysis

8.1 Enasidenib Industrial Chain

8.2 Enasidenib Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Enasidenib Sales Model

8.5.2 Sales Channel

8.5.3 Enasidenib Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Enasidenib Market Trends

Table 2. Enasidenib Market Drivers & Opportunity

Table 3. Enasidenib Market Challenges

Table 4. Enasidenib Market Restraints

Table 5. Global Enasidenib Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Enasidenib Revenue Market Share by Company (2019-2024)

Table 7. Global Enasidenib Sales Volume by Company (2019-2024) & (Units)

Table 8. Global Enasidenib Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Enasidenib Price by Company (2019-2024) & (USD/Unit)

Table 10. Key Manufacturers Enasidenib Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Enasidenib Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Enasidenib

Table 13. Global Enasidenib Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enasidenib as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Enasidenib Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Enasidenib Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Enasidenib Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Enasidenib Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Enasidenib Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Enasidenib Sales Volume by Type: 2019 VS 2023 VS 2030 (Units)

Table 22. Global Enasidenib Sales Volume by Type (2019-2024) & (Units)

Table 23. Global Enasidenib Sales Volume by Type (2025-2030) & (Units)

Table 24. Global Enasidenib Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Enasidenib Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Enasidenib Price by Type (2019-2024) & (USD/Unit)

Table 27. Global Enasidenib Price by Type (2025-2030) & (USD/Unit)

Table 28. Global Enasidenib Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Enasidenib Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Enasidenib Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Enasidenib Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Enasidenib Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Enasidenib Sales Volume by Application: 2019 VS 2023 VS 2030 (Units)

Table 34. Global Enasidenib Sales Volume by Application (2019-2024) & (Units)

Table 35. Global Enasidenib Sales Volume by Application (2025-2030) & (Units)

Table 36. Global Enasidenib Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Enasidenib Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Enasidenib Price by Application (2019-2024) & (USD/Unit)

Table 39. Global Enasidenib Price by Application (2025-2030) & (USD/Unit)

Table 40. Global Enasidenib Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Enasidenib Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Enasidenib Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Enasidenib Sales Value by Region (2019-2024) & (%)

Table 44. Global Enasidenib Sales Value by Region (2025-2030) & (%)

Table 45. Global Enasidenib Sales Volume by Region (Units): 2019 VS 2023 VS 2030

Table 46. Global Enasidenib Sales Volume by Region (2019-2024) & (Units)

Table 47. Global Enasidenib Sales Volume by Region (2025-2030) & (Units)

Table 48. Global Enasidenib Sales Volume by Region (2019-2024) & (%)

Table 49. Global Enasidenib Sales Volume by Region (2025-2030) & (%)

Table 50. Global Enasidenib Average Price by Region (2019-2024) & (USD/Unit)

Table 51. Global Enasidenib Average Price by Region (2025-2030) & (USD/Unit)

Table 52. Key Countries/Regions Enasidenib Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Enasidenib Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Enasidenib Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Enasidenib Sales Volume, (2019-2024) & (Units)

Table 56. Key Countries/Regions Enasidenib Sales Volume, (2025-2030) & (Units)

Table 57. Bristol Myers Squibb Company Information

Table 58. Bristol Myers Squibb Introduction and Business Overview

Table 59. Bristol Myers Squibb Enasidenib Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 60. Bristol Myers Squibb Enasidenib Product Offerings

Table 61. Bristol Myers Squibb Recent Development

Table 62. Key Raw Materials Lists

Table 63. Raw Materials Key Suppliers Lists

Table 64. Enasidenib Downstream Customers

Table 65. Enasidenib Distributors List

Table 66. Research Programs/Design for This Report

Table 67. Key Data Information from Secondary Sources

Table 68. Key Data Information from Primary Sources

List of Figures

Figure 1. Enasidenib Product Picture

Figure 2. Global Enasidenib Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Enasidenib Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Enasidenib Sales Volume (2019-2030) & (Units)

Figure 5. Global Enasidenib Sales Price (2019-2030) & (USD/Unit)

Figure 6. Enasidenib Report Years Considered

Figure 7. Global Enasidenib Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Enasidenib Players Sales Volume Ranking (2023) & (Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Enasidenib Revenue in 2023

Figure 10. Enasidenib Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. 50mg Picture

Figure 12. 100mg Picture

Figure 13. Global Enasidenib Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Enasidenib Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Enasidenib Sales Volume by Type (2019 VS 2023 VS 2030) & (Units)

Figure 16. Global Enasidenib Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Enasidenib Price by Type (2019-2030) & (USD/Unit)

Figure 18. Product Picture of Hospital

Figure 19. Product Picture of Pharmacy

Figure 20. Global Enasidenib Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 21. Global Enasidenib Sales Value Market Share by Application, 2023 & 2030

Figure 22. Global Enasidenib Sales Volume by Application (2019 VS 2023 VS 2030) & (Units)

Figure 23. Global Enasidenib Sales Volume Market Share by Application, 2023 & 2030

Figure 24. Global Enasidenib Price by Application (2019-2030) & (USD/Unit)

Figure 25. North America Enasidenib Sales Value (2019-2030) & (US$ Million)

Figure 26. North America Enasidenib Sales Value by Country (%), 2023 VS 2030

Figure 27. Europe Enasidenib Sales Value (2019-2030) & (US$ Million)

Figure 28. Europe Enasidenib Sales Value by Country (%), 2023 VS 2030

Figure 29. Asia Pacific Enasidenib Sales Value (2019-2030) & (US$ Million)

Figure 30. Asia Pacific Enasidenib Sales Value by Country (%), 2023 VS 2030

Figure 31. South America Enasidenib Sales Value (2019-2030) & (US$ Million)

Figure 32. South America Enasidenib Sales Value by Country (%), 2023 VS 2030

Figure 33. Middle East & Africa Enasidenib Sales Value (2019-2030) & (US$ Million)

Figure 34. Middle East & Africa Enasidenib Sales Value by Country (%), 2023 VS 2030

Figure 35. Key Countries/Regions Enasidenib Sales Value (%), (2019-2030)

Figure 36. Key Countries/Regions Enasidenib Sales Volume (%), (2019-2030)

Figure 37. United States Enasidenib Sales Value, (2019-2030) & (US$ Million)

Figure 38. United States Enasidenib Sales Value by Type (%), 2023 VS 2030

Figure 39. United States Enasidenib Sales Value by Application (%), 2023 VS 2030

Figure 40. Europe Enasidenib Sales Value, (2019-2030) & (US$ Million)

Figure 41. Europe Enasidenib Sales Value by Type (%), 2023 VS 2030

Figure 42. Europe Enasidenib Sales Value by Application (%), 2023 VS 2030

Figure 43. China Enasidenib Sales Value, (2019-2030) & (US$ Million)

Figure 44. China Enasidenib Sales Value by Type (%), 2023 VS 2030

Figure 45. China Enasidenib Sales Value by Application (%), 2023 VS 2030

Figure 46. Japan Enasidenib Sales Value, (2019-2030) & (US$ Million)

Figure 47. Japan Enasidenib Sales Value by Type (%), 2023 VS 2030

Figure 48. Japan Enasidenib Sales Value by Application (%), 2023 VS 2030

Figure 49. South Korea Enasidenib Sales Value, (2019-2030) & (US$ Million)

Figure 50. South Korea Enasidenib Sales Value by Type (%), 2023 VS 2030

Figure 51. South Korea Enasidenib Sales Value by Application (%), 2023 VS 2030

Figure 52. Southeast Asia Enasidenib Sales Value, (2019-2030) & (US$ Million)

Figure 53. Southeast Asia Enasidenib Sales Value by Type (%), 2023 VS 2030

Figure 54. Southeast Asia Enasidenib Sales Value by Application (%), 2023 VS 2030

Figure 55. India Enasidenib Sales Value, (2019-2030) & (US$ Million)

Figure 56. India Enasidenib Sales Value by Type (%), 2023 VS 2030

Figure 57. India Enasidenib Sales Value by Application (%), 2023 VS 2030

Figure 58. Enasidenib Industrial Chain

Figure 59. Enasidenib Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which region is expected to have the highest market share? zhanKai

For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 7.1% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.

What was the global market size of Enasidenib in 2030? shouQi

Which companies rank high in the global Enasidenib market? shouQi

What was the global market size of Enasidenib in 2024? shouQi

What is the annual compound growth rate of the global Enasidenib market size from 2024 to 2030? shouQi

Related Reports

Enasidenib- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Enasidenib was estimated to be worth US$ 94.4 million in 2025 and is projected to reach US$ 152 million, growing at a CAGR of 7.1% from 2026 to 2032.
Published Date: 2026-07-14
Pages: 125
USD 3950.00
(Single User License)
Global Enasidenib Market Research Report 2026
The global Enasidenib market was valued at US$ 94.4 million in 2025 and is anticipated to reach US$ 152 million by 2032, at a CAGR of 7.1% from 2026 to 2032.
Published Date: 2026-04-27
Pages: 106
USD 2900.00
(Single User License)
Global Enasidenib Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Enasidenib market size was US$ 88.7 million in 2024 and is forecast to a readjusted size of US$ 142 million by 2031 with a CAGR of 7.1% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 70
USD 4250.00
(Single User License)
Enasidenib- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Enasidenib was estimated to be worth US$ 88.7 million in 2024 and is forecast to a readjusted size of US$ 142 million by 2031 with a CAGR of 7.1% during the forecast period 2025-2031.
Published Date: 2025-02-25
Pages: 87
USD 3950.00
(Single User License)
Global Enasidenib Market Research Report 2025
The global market for Enasidenib was valued at US$ 88.7 million in the year 2024 and is projected to reach a revised size of US$ 142 million by 2031, growing at a CAGR of 7.1% during the forecast period.
Published Date: 2025-02-25
Pages: 74
USD 2900.00
(Single User License)
Global Enasidenib Market Insights, Forecast to 2030
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) gene, determined by an FDA-approved IDH2 companion diagnostic test
Published Date: 2024-04-25
Pages: 72
USD 4900.00
(Single User License)
Global Enasidenib Market Research Report 2024
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) gene, determined by an FDA-approved IDH2 companion diagnostic test
Published Date: 2024-01-05
Pages: 67
USD 2900.00
(Single User License)

Enasidenib- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Enasidenib was estimated to be worth US$ 94.4 million in 2025 and is projected to reach US$ 152 million, growing at a CAGR of 7.1% from 2026 to 2032.
Published: 2026-07-14
Pages: 125
USD 3950.00 (Single User License)
Global Enasidenib Market Research Report 2026
The global Enasidenib market was valued at US$ 94.4 million in 2025 and is anticipated to reach US$ 152 million by 2032, at a CAGR of 7.1% from 2026 to 2032.
Published: 2026-04-27
Pages: 106
USD 2900.00 (Single User License)
Global Enasidenib Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Enasidenib market size was US$ 88.7 million in 2024 and is forecast to a readjusted size of US$ 142 million by 2031 with a CAGR of 7.1% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 70
USD 4250.00 (Single User License)
Enasidenib- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Enasidenib was estimated to be worth US$ 88.7 million in 2024 and is forecast to a readjusted size of US$ 142 million by 2031 with a CAGR of 7.1% during the forecast period 2025-2031.
Published: 2025-02-25
Pages: 87
USD 3950.00 (Single User License)
Global Enasidenib Market Research Report 2025
The global market for Enasidenib was valued at US$ 88.7 million in the year 2024 and is projected to reach a revised size of US$ 142 million by 2031, growing at a CAGR of 7.1% during the forecast period.
Published: 2025-02-25
Pages: 74
USD 2900.00 (Single User License)
Global Enasidenib Market Insights, Forecast to 2030
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) gene, determined by an FDA-approved IDH2 companion diagnostic test
Published: 2024-04-25
Pages: 72
USD 4900.00 (Single User License)
Global Enasidenib Market Research Report 2024
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) gene, determined by an FDA-approved IDH2 companion diagnostic test
Published: 2024-01-05
Pages: 67
USD 2900.00 (Single User License)